Abnormal Regulation, Estimation and Cognitive Impacts of Physical Efforts as an Endophenotype of Anorexia Nervosa (CAPANOX)

January 23, 2018 updated by: Centre Hospitalier St Anne

Analysis of the Capacity to Regulate Physical Efforts and to Estimate Its Intensity as an Endophenotype of Anorexia Nervosa, Because of a Specific Impact of the Physical Effort at the Emotional, Cognitive, Pain, Genetic and Biological Level

The purpose of this study is to check if patients, but also relatives (as they share familial and genetic risk factors), are having more difficulties in regulating a spontaneous, pleasant physical effort (doing "too much") compared to healthy controls, and if physical efforts are participating to core symptoms of anorexia nervosa, such as more appetite (instead of less), less pain, more abnormal body image, and less cognitive flexibility.

Such a result could help to further understand the role of difficulties with physical exercise as part of the phenotype of anorexia nervosa.

Study Overview

Detailed Description

This is a three steps protocol. First, patients (with anorexia nervosa), controls (with no eating disorder) and first degree relatives (with no eating disorder) will be tested for emotional accuracy (seing faces on a screen with different core emotions), pain threshold (how long they can support a cold probe), body size (how they see themselves), appetite and cognitive flexibility (a test where the capacity to change rules during a game is done easily or not).

Then all subjects will do a standardized physical exercise which represents an effort with the equivalent level of energy for each participants as being chosen according to each level of competency (assessed through the "maximal aerobic power").

The third step consists in the repetition of (nearly) initial tests.

Study Type

Interventional

Enrollment (Anticipated)

180

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

Patients :

  • Woman
  • 18 - 50 years
  • eating disorders (with or without bulimia) according to the EDI-2 (Eating Disorder Inventory) and the MINI (Mini International Neuropsychiatric Interview)
  • BMI (Body Mass index) between 14 and 17,5
  • first degree relative without ED (eating disorders)

First degree relatives :

  • Woman
  • 18 - 50 years
  • Mother or sister of patient with eating disorders
  • BMI (Body Mass index) upper to 17,5
  • Healthy of all ED (eating disorders)

Controls :

  • Woman
  • 18 - 50 years
  • BMI > 17,5
  • Without ED (eating disorders)

Exclusion Criteria:

All groups :

  • Contraindication in the practice of an intensive sport
  • Cardiovascular Family history with risk of cardiovascular unwanted events
  • Cardiovascular, surgical personal Histories, ostéoarticulaires or musculo-tendinous against indicating to the practice of a sport
  • Intercurrents psychiatric pathologies (humor or psychotics disorders, chronic or acute)

Related and controls :

Diagnosis of ED (eating disorders) in the EDI-2 and in the MINI

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Anorexia nervosa
Patients with DSM-5 criteria of "anorexia nervosa"
Clinical and biological examination, Saliva (or blood) test, glycemia, thermal test, cognitive and bike tests, questionnaires
Other: First degree relatives
First degree relatives (of patients suffering from anorexia nervosa) with no eating disorder
Clinical examination, Glycemia, saliva (or blood) test, thermal test, cognitive and bike tests, questionnaires
Other: Controls (with no eating disorder)
Other
Clinical examination, Glycemia, saliva (or blood) test, thermal test, cognitive and bike tests, questionnaires

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical power
Time Frame: Day 0
Comparison inter and intra individual of the subjective and objective power to the subjects during a typical physical bike test.
Day 0

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain threshold
Time Frame: Day 0

This threshold is based on the minimum temperature that the patient is able to suppor (the probe is placed on the skin of the forarm, and the temperature reduces its temperature every 10 seconds), knowing that the machine is not getting to temperatures that can be damageable.

Comparison before and after bike test

Day 0
Wellbeing self-questionnaire
Time Frame: Day 0
Comparison before and after bike test
Day 0
Hunger Visual analogical scale
Time Frame: Day 0
Comparison before and after bike test
Day 0
PANAS score (self-questionnaire)
Time Frame: Day 0
Emotions. Comparison before and after bike test
Day 0
Hunger Visual analogical scale
Time Frame: Day 0
Apetite. Comparison before and after bike test
Day 0
Performance on the Briton cognitive test (number of errors)
Time Frame: Day 0
Mental flexibility. Comparison before and after bike test
Day 0
Performance on cognitive tests (speed, number of errors), before versus after the exercise, in the three groups.
Time Frame: Day 0
Tests. Performance on cognitive tests (speed, number of errors), before versus after the exercise, in the three groups.
Day 0
Genetical analysis
Time Frame: Day 0
10 candidate genes will be analyzed (following the collection of blood or saliva) assessing the frequency of their main alleles (variants), looking for a significant difference of allele frequency between the 3 groups.
Day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Philip GORWOOD, MD, PhD, CHSA

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 27, 2017

Primary Completion (Anticipated)

April 1, 2020

Study Completion (Anticipated)

September 1, 2020

Study Registration Dates

First Submitted

December 5, 2016

First Submitted That Met QC Criteria

December 13, 2016

First Posted (Estimate)

December 16, 2016

Study Record Updates

Last Update Posted (Actual)

January 25, 2018

Last Update Submitted That Met QC Criteria

January 23, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • D15-P018

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anorexia Nervosa

Clinical Trials on Clinical and biological examination, Saliva (or blood) test Glycemia, thermal test, cognitive and bike tests, questionnaires

3
Subscribe